Classification
- Anatomical main groupSSensory organs
- Therapeutic subgroupS01Ophthalmologicals
- Pharmacological subgroupS01L
- Chemical subgroupS01LA
- Chemical substanceS01LA09Faricimab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 5 registrations
- Vabysmo 120 MG/ML Solucion Inyectable28,8 mg · solución inyectable · Roche Registration Gmbh · Marketed · 2 entries
- Vabysmo 120 MG/ML Solucion Inyectable28,8 mg · solución inyectable · Roche Registration Gmbh · Authorised
- Vabysmo 120 MG/ML Solucion Para Inyeccion en Jeringa Precargada21 mg · solución inyectable en jeringa precargada · Roche Registration Gmbh
Canada
Health Canada · 2 registrations
Singapore
HSA · 2 registrations
At a glance
- ATC code
- S01LA09
- ATC group
- Sensory organs
- Registers
- 10
- Historical lists
- 1
- Registrations
- 18
- With their own page
- 17
- Companies
- 7
All medicines with Faricimab
Human medicines from every register that match Faricimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
18 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Vabysmo | United States | 120MG/ML | injectable | Marketed | Genentech INC |
| Vabysmo | United States | 6MG/0.05ML | Injection | Marketed | Genentech, Inc. |
| Vabysmo | European Union | Authorised | Roche Registration GmbH | ||
| Vabysmo 120 MG/ML Solucion Inyectable | Spain | 28,8 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Vabysmo 120 MG/ML Solucion Inyectable | Spain | 28,8 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Vabysmo 120 MG/ML Solucion Para Inyeccion en Jeringa Precargada | Spain | 21 mg | solución inyectable en jeringa precargada | Marketed | Roche Registration Gmbh |
| Vabysmo 120 mg/ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Roche Registration GmbH | |
| Vabysmo 120 MG/ML Solucion Inyectable | Spain | 28,8 mg | solución inyectable | Authorised | Roche Registration Gmbh |
| Vabysmo 120 MG/ML Solucion Para Inyeccion en Jeringa Precargada | Spain | 21 mg | solución inyectable en jeringa precargada | Authorised | Roche Registration Gmbh |
| Vabysmo | Canada | 6 MG / 0.05 ML | Solution | Marketed | Hoffmann-LA Roche Limited |
| Vabysmo | Canada | 6 MG / 0.05 ML | Solution | Marketed | Hoffmann-LA Roche Limited |
| Vabysmo Solution for Injection 6MG/0.05ML | Singapore | 6.00mg/0.05ml | injection, solution | Authorised | Roche Singapore Pte. LTD. |
| Vabysmo Solution for Injection in Pre-Filled Syringe 6MG/0.05ML | Singapore | 6.0 mg/0.05 mL | injection, solution | Authorised | Roche Singapore Pte. LTD. |
| Vabysmo | Brazil | Authorised | Produtos Roche Químicos e Farmacêuticos S.A. | ||
| Vabysmo® | Serbia | 120mg/mL | rastvor za injekciju | Authorised | Roche DOO Beograd |
| Vabysmo | Croatia | Marketed | |||
| Vabysmo | New Zealand | Inj 120 mg per ml, 0.24 ml vial | Funded | ||
| Vabysmo 6 mg per 0.05 ml | Saudi Arabia | Authorised | F. Hoffmann-La Roche Ltd. |